BSENational Peroxide LtdHighNeutral
Announced Thu, 30 Apr · 21:44 IST

Please find attached Financial Results.

Pat Growth 25pctEbitda Margin ExpansionEmphasis Of MatterExceptional ItemResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+40.2%1-day move
₹460.00
prior close
₹547.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+40.2+42.0+48.9+41.7+44.8+39.1+32.6+24.7+30.2
Up moveDown movePending
AI summary

National Peroxide Limited reported audited financial results for FY26 ending March 31, 2026. Total income was Rs 29,136 lakhs vs Rs 28,971 lakhs in FY25, showing marginal revenue growth of less than 1%. However, Profit After Tax (PAT) improved significantly to Rs 1,104 lakhs from Rs 793 lakhs in the prior year, representing PAT growth of approximately 39%. The Board recommended a final dividend of Rs 7 per share (70% payout) subject to shareholder approval. The statutory auditors issued an unmodified (clean) opinion. Key management changes include Mr. Amit Goriwale stepping down as Interim CFO & CRO (effective May 31, 2026) and Mr. Chirag Kothari being appointed as the new CFO & CRO (effective June 1, 2026). An exceptional item of Rs 58 lakhs was recorded due to the implementation of the Code on Social Security, 2020.

Likely market impact

The company showed strong profitability improvement with PAT growth of ~39% despite flat revenue, indicating better cost management and operational efficiency. The clean audit opinion and dividend recommendation are positive signals for shareholders. The CFO transition appears planned and smooth.